RA Capital Directors Receive Stock Options in Bicara Therapeutics

This Form 4 filing discloses that RA Capital Management, L.P. and its related entities, including directors Peter Kolchinsky, Rajeev Shah, and Jake Simson, received stock options in Bicara Therapeutics Inc. (BCAX). The filing reports the grant of 19,475 stock options to Jake Simson, a Partner of RA Capital who serves on Bicara's board of directors, pursuant to the company's Non-Employee Director Compensation Policy. The options have an exercise price of $20.56 and expire on June 9, 2036. The shares will vest on the earlier of June 9, 2027 or the date of the next Annual Meeting of Stockholders, subject to Simson's continued service. Notably, the filing indicates that Simson holds the options for the benefit of RA Capital's funds, and any proceeds from exercise will offset advisory fees owed to RA Capital. The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.